Goldenwell Biotech, Inc. (GWLL)

Goldenwell Biotech Revenue

Goldenwell Biotech had revenue of $55.00 in the twelve months ending March 31, 2026, down -60.43% year-over-year. In the year 2025, Goldenwell Biotech had annual revenue of $55.00, down -60.43%.

• Revenue: 55.00
• Revenue Growth: -60.43%
• P/S Ratio: 936,000.00
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 51.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	55.00	-84.00	-60.43%
Dec 31, 2024	139.00	-1.70K	-92.43%
Dec 31, 2023	1.84K	-45.96K	-96.16%
Dec 31, 2022	47.80K	31.83K	199.37%
Dec 31, 2021	15.97K	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error